Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1992-3-16
|
pubmed:abstractText |
To determine if bone cells produce interleukin-1 beta (IL-1 beta), a potent bone resorption-stimulating agent, we studied well-characterized, nearly homogeneous cultures of normal human osteoblast-like (hOB) cells. With four strains of such cells, vehicle-treated cultures produced minimal IL-1 beta (mean +/- SEM, 1.3 +/- 0.3 pg/ml per 10(6) cells per 24 h) and showed dose-dependent (r = 0.99) increases to 2.2 +/- 0.7, 5.0 +/- 0.9, or 17.8 +/- 6.7 pg/ml, respectively, after treatment with lipopolysaccharide (LPS) at 3, 10, or 30 micrograms/ml (for increases after 10 and 30 micrograms/ml treatments, P less than 0.05). After treatment with tumor necrosis factor alpha (TNF-alpha) at 10 U/ml, IL-1 beta increased to 16.2 +/- 3.7 pg/ml (P less than 0.05). Neither 17 beta-estradiol nor bovine parathyroid hormone(1-34) (each at 10 nM), alone or in combination with LPS or TNF-alpha, affected IL-1 beta release. Northern blot analysis of total cellular RNA preparation revealed a single hybridization band at 1.9 kb when probed with a partially deleted cDNA for human IL-1 beta. The steady-state IL-1 beta mRNA levels showed a significant increase with LPS treatment and a lesser increase with TNF-alpha treatment in hOB cells. Moreover, TNF-alpha produced an even greater increase in IL-1 mRNA in HOBIT cells, a well-differentiated clonal cell line derived from normal hOB cells transfected with the SV40 large T antigen. We conclude that human cells of the osteoblast lineage produce IL-1 beta in response to well-recognized stimuli for IL-1 release from responsive tissue.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Polyomavirus Transforming,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Parathyroid Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Teriparatide,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0884-0431
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
827-33
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1785373-Antigens, Polyomavirus Transforming,
pubmed-meshheading:1785373-Bone Resorption,
pubmed-meshheading:1785373-Cell Line,
pubmed-meshheading:1785373-Cells, Cultured,
pubmed-meshheading:1785373-Dose-Response Relationship, Drug,
pubmed-meshheading:1785373-Drug Interactions,
pubmed-meshheading:1785373-Estradiol,
pubmed-meshheading:1785373-Humans,
pubmed-meshheading:1785373-Interleukin-1,
pubmed-meshheading:1785373-Lipopolysaccharides,
pubmed-meshheading:1785373-Osteoblasts,
pubmed-meshheading:1785373-Parathyroid Hormone,
pubmed-meshheading:1785373-Peptide Fragments,
pubmed-meshheading:1785373-RNA, Messenger,
pubmed-meshheading:1785373-Teriparatide,
pubmed-meshheading:1785373-Tumor Necrosis Factor-alpha
|
pubmed:year |
1991
|
pubmed:articleTitle |
Evidence for interleukin-1 beta production by cultured normal human osteoblast-like cells.
|
pubmed:affiliation |
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|